Results 221 to 230 of about 67,769 (290)

Stapokibart for moderate-to-severe seasonal allergic rhinitis: a randomized phase 3 trial

Nature Medicine
Seasonal allergic rhinitis (SAR) places a significant socioeconomic burden, particularly on individuals with poorly managed recurrent and severe symptoms despite standard-of-care treatment.
Yuan Zhang, Jingyun Li, Menglin Wang, Xian Li, Bing Yan, Jixiang Liu, Li Shi, Zhiwei Cao, Yan Feng, Weiwei Liu, Zhendong Xu, Ruixia Ma, Xiaoping Gao, Wen Liu, Jinmei Xue, Xiaoyong Ren, Xuezhong Li, Xicheng Song, Yi Yang, Yusheng Wang, Zhimin Xing, F. Quan, Jing Pan, Yue Sun, F. Shi, Xiaoqiu Chen, Hongyue Yan, Guoqing Zhao, Bo Chen, Chengshuo Wang, Luo Zhang   +30 more
semanticscholar   +1 more source

Seasonal allergic rhinitis

Practice Nursing, 1998
Seasonal allergic rhinitis can have a considerable effect on the quality of life of sufferers, and requires effective management.
openaire   +1 more source

Seasonal Allergic Rhinitis

2018
Allergic rhinitis is a significant chronic health problem worldwide. It can be divided into seasonal and perennial classifications based on the timing of symptoms and the causative agents. Empiric treatment can be initiated without allergy testing, but testing is required for definitive diagnosis and consideration of certain trigger-specific therapies ...
Roua Azmeh, Mark S. Dykewicz
openaire   +1 more source

Comparison of the efficacy and mechanisms of intranasal budesonide, montelukast, and their combination in treatment of patients with seasonal allergic rhinitis

International Forum of Allergy and Rhinology, 2018
Although intranasal steroids and anti–cysteinyl‐leukotriene‐receptor antagonists are efficacious in the treatment of seasonal allergic rhinitis (SAR), combinations of these agents have not unequivocally been demonstrated to be superior to the individual ...
H. Chen, H. Lou, Yang Wang, F. Cao, Luo Zhang, Chengshuo Wang   +5 more
semanticscholar   +1 more source

Reduced Airway Absorption in Seasonal Allergic Rhinitis

American Journal of Respiratory and Critical Care Medicine, 1997
The common notion that increased mucosal absorption characterizes allergic and inflamed airways is poorly supported by physiologic in vivo data. We have now examined whether the airway mucosa of patients with seasonal allergic rhinitis develop a change in absorption during their active disease period.
L, Greiff, M, Andersson, C, Svensson, S, Lundin, P, Wollmer, C G, Persson   +5 more
openaire   +2 more sources

Study of levocetirizine in seasonal allergic rhinitis

Current Medical Research and Opinion, 2010
To evaluate the efficacy of levocetirizine 5 mg once daily in reducing seasonal allergic rhinitis (SAR) symptoms in US adults.This multicenter, randomized, double-blind, placebo-controlled, parallel-group study enrolled adults aged 18 to 65 years with SAR symptoms in the spring in the US.
Lyndon E, Mansfield, Frank, Hampel, Jean-Marc C, Haeusler, George, Georges   +3 more
openaire   +2 more sources

Pathophysiology and treatment of seasonal allergic rhinitis

Respiratory Medicine, 1990
Therapeutic approaches to seasonal allergic rhinitis are reviewed in this paper. Pharmacotherapeutic approaches include nonsedative antihistamines, anti-allergic drugs, vasoconstrictors, anticholinergic agents and topical corticosteroids. The choice of treatment depends upon its relative efficacy and safety.
J, Bousquet, P, Chanez, F B, Michel
openaire   +2 more sources

Budesonide once-daily in seasonal allergic rhinitis

Current Medical Research and Opinion, 1991
A randomized, parallel group, double-blind multi-centre study was carried out in 342 patients with symptomatic seasonal allergic rhinitis to assess the efficacy and tolerability of intranasal budesonide administered either as a single morning dose of 400 micrograms or as a 200 micrograms twice-daily dose, morning and evening, for 4 weeks.
J R, Ross, G, Mohan, B, Andersson, M D, Taylor, P D, Richardson   +4 more
openaire   +2 more sources

TRPV1‐mediated itch in seasonal allergic rhinitis

Allergy, 2009
Background:  Patients with allergic rhinitis may be abnormally sensitive to stimulation of the ion channel transient receptor potential vanilloid‐1 (TRPV1).Aim of the study:  To examine effects of various TRP ion channel activators on sensory symptoms in allergic rhinitis prior to and during seasonal allergen exposure.Methods:  Nasal challenges were ...
L, Alenmyr, E D, Högestätt, P M, Zygmunt, L, Greiff   +3 more
openaire   +2 more sources

[Seasonal allergic rhinitis].

Revue medicale suisse
Allergic diseases are currently amongst the most frequent diseases of our time. Of all the allergies in the Western countries, allergic rhinoconjunctivitis is the most common. Its diagnosis is based mainly on the history and the correlation between symptoms and contact with the allergen.
Igor, Salvadé, Laura, Moi, Camillo, Ribi, François, Spertini   +3 more
openaire   +1 more source